Prognos is the largest repository of clinical laboratory results in the US. With linkability to other secondary data, we provide valuable insights into patient health status for RWE and HEOR research.
Stop by our ISPOR Theater Presentation!
Monday, May 20, 2019, 11:15 - 11:45am (EST)
Getting to the “Why”: Gaining Additional Insights for HEOR Studies Through Diagnostic Laboratory Data
- Prognos: Heather von Allmen, VP, HEOR/RWE
- Amgen: Mohdhar Habib: Director, Global Health Economics
This presentation will provide an overview of how diagnostic laboratory data can be used to provide a deeper level of understanding of patients when conducting Health Economic or Outcomes studies using secondary data. In addition to the overview, a use case will be presented by Amgen that details how diagnostic lab data was used to characterize patients selected for treatment with lipid lowering therapies and the additional value they gained through having this included in their research.
*The HEOR Theater presentations are not an official educational offering of ISPOR 2019 New Orleans, and are not sponsored, endorsed or accredited by ISPOR